Dissemination (Meeting Coverage)

Check out the key presentations from AAN Fall Clinical on MS. And follow along for more from AAN.

Educational and research gaps in treating plaque psoriasis in patients with skin of color can lead to delays in diagnosis and treatment.

Take a look at the schedule for AAN Fall Conference. And follow along at PW for conference coverage.

Take a look at some of the fun facts about AAN Fall Conference. And follow PW for conference coverage.

For a retrospective study involving 607 oncology patients treated from 2014-2019, the potential for predicting patient prognosis and guiding immunotherapy treatment through the analysis of total tumor volume (TTV) and artificial intelligence (AI) tumor heterogeneity from CT scans was investigated.

In early-stage non-small cell lung cancer (NSCLC), the recommended treatment options include targeted and immune therapies.

In the management of early-stage non-small cell lung cancer (eNSCLC), the introduction of PD-1/PD-L1 checkpoint inhibitors has marked a significant advancement.

Cancer-associated fibroblasts (CAFs) constitute a critical element of the tumor microenvironment, and TGFβ-induced CAFs have been implicated in poor prognosis across various indications.

One of ESMO’s most popular track is its Young Oncologist Track designed and initiated by the ESMO Young Oncologist Committee.

There are more than 50 satellite symposia sessions taking place at ESMO. Follow PW for conference coverage.

Take a look at ESMO’s keynote sessions and full schedule. Follow PW for conference coverage.